Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Eur Urol. 2018 Sep 17;75(2):221–228. doi: 10.1016/j.eururo.2018.08.039

Table 2 –

Preoperative and postoperative erectile function of patients treated with bilateral nerve-sparing surgery and being free from adjuvant or salvage treatment at the time of erectile function assessment

Baseline IIEF-6 score, median (IQR) 27 (19–30)
EF recovery at 12 mo post-RP, n (%) 483 (27) a
EF recovery at 24 mo post-RP, n (%) 377 (34) a
Regular use of PDE5is, n (%)
    12-mo assessment 716 (40) a
    24-mo assessment 158 (14) a
Use of ICI over the follow-up period, n (%) 741 (31)

EF = erectile function; ICI = intracavernous injection; IIEF = International Index of Erectile Function; IQR = interquartile range; PDE5is = phosphodiesterase type 5 inhibitors; RP = radical prostatectomy.

a

A total of 1779 and 1095 patients treated with bilateral nerve-sparing surgery were free from adjuvant/salvage treatment at the 12- and 24-mo assessment, respectively.